Marc Cantillon
2022
In 2022, Marc Cantillon earned a total compensation of $348.6K as Former Chief Medical Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 31% decrease compared to previous year.
Compensation breakdown
| Bonus | $115,500 |
|---|---|
| Salary | $233,087 |
| Total | $348,587 |
Cantillon received $233.1K in salary, accounting for 67% of the total pay in 2022.
Cantillon also received $115.5K in bonus.
Rankings
In 2022, Marc Cantillon's compensation ranked 4,876th out of 5,669 executives tracked by ExecPay. In other words, Cantillon earned more than 14.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,876 out of 5,669 | 14th |
Division Manufacturing | 2,697 out of 3,081 | 13th |
Major group Chemicals And Allied Products | 1,268 out of 1,396 | 9th |
Industry group Drugs | 1,192 out of 1,297 | 8th |
Industry Pharmaceutical Preparations | 865 out of 940 | 8th |
Source: SEC filing on October 4, 2023.
Cantillon's colleagues
We found two more compensation records of executives who worked with Marc Cantillon at REVIVA PHARMACEUTICALS HOLDINGS in 2022.